Setting the standard in gut health
Scientific research and clinical evidence are at the heart of everything we do. Why? Because your gut is worth more than guesswork.
Our fibre blends are based on over a decade of research at MIT and developed by our in-house team of gut microbiome scientists and dietitians. Our unique formulations are patent-protected, so you won't find them anywhere else. They're extensively tested, clinically proven and trusted by NHS clinicians.
We're so confident in the power of our blends that we've invested over a million pounds in clinical trials.
The results are there to read for yourself — including where the evidence is strong and where we're still building it. No gimmicks. No empty promises. Just data you can trust. Our in-vivo studies have been peer-reviewed and published in renowned journals — and leading universities and gut-health clinics choose myota as their research partner.
reduction in blood sugar levels when taking myota with a meal.
Myota fibre reduces blood sugar spikes
Flattening the post-meal glucose curve — steadier energy, and fuller for longer, without anything harsh on your gut.
Our own blends, tested in human trials
Most fibre supplements combine common ingredients and lean on the general evidence for fibre. We go further — running randomised, placebo-controlled trials on our specific formulations, then publishing the results in peer-reviewed journals.
Fibre supplements for pre-diabetes
A 24-week randomised, placebo-controlled trial in 66 adults with pre-diabetes, taking 20g of our prebiotic blend daily. Compared with placebo, HbA1c, insulin sensitivity, fasting insulin and C-reactive protein all improved significantly, without changes to diet or lifestyle. Published in the British Journal of Nutrition.
Prebiotic intervention for metabolic & mental health
A 12-week randomised controlled trial in 60 adults with metabolic syndrome, taking 10g of our prebiotic blend daily. Inflammation (hs-CRP) fell, gut microbiome composition shifted, and sub-clinical stress, anxiety and depression scores improved. Published in the British Journal of Nutrition.
Prebiotic fibre, cognition and mood in older adults
A pilot double-blind, randomised, placebo-controlled trial in 50 healthy adults aged 60-75 with mild to moderate subjective cognitive complaints, taking 10g of a prebiotic fibre blend daily for 12 weeks. Outcomes covered overall and domain-specific cognitive performance, depression and anxiety symptoms, gut symptoms, blood pressure, body measurements and microbiome diversity.
Prebiotic-fortified bakery products in older adults
A randomised controlled trial at the University of Reading, funded by Innovate UK and BBSRC, testing a bakery product enriched with our prebiotic fibre blend in older adults. Outcomes cover cognition, mood, inflammation and metabolic health. Results are in preprint.
Can a prebiotic fibre blend improve stress, mood and anxiety?
A 12-week double-blind, placebo-controlled trial in healthy adults with mild to severe stress, testing whether a daily prebiotic fibre blend lowers perceived stress. Secondary measures cover mood, inflammation and the gut microbiome.
Prebiotic fibre and affect, inflammation and cognition
A double-blind, placebo-controlled trial examining the effect of a daily prebiotic fibre blend on stress, with secondary outcomes across depression, mood, anxiety, cognition, inflammation and the gut microbiome.
Our clinical evidence base is genuine but still young. Established fibres like psyllium are backed by decades of independent trials — we're building that depth now, with an active pipeline and independent replication as the goal.
The research doesn't stop at our founding.
Our roots are in a decade of microbiome research — but the work is ongoing. We have registered trials, both completed and in progress, studying metabolism, blood sugar regulation, inflammation and mental-health outcomes, and we reformulate as new evidence emerges. Science is our operating system, not a founding story.
The science behind the benefits
Fibre & chronic inflammation
The short-chain fatty acid butyrate has a key role in reducing inflammation and preventing inflammation-associated diseases.
Read the research
Fibre for a healthy metabolism
A tool in preventing — and even reversing — Type 2 diabetes. Fibre reduces post-meal glucose spikes and lowers cholesterol, a key risk factor in heart disease.
Read the research
Mental well-being & fibre
Microbial SCFAs are linked to improved mental well-being — from how we manage anxiety, stress and depression to how our brains age.
Read the researchWhat's in it — and how we're tested
You should know exactly what you're consuming. We name every fibre in our blends and are honest about where our quality transparency is strong and where we're still improving.
A proprietary blend, named ingredients
Our proprietary blend combines natural fibres in a unique way, designed to work across different microbiome compositions. This maximises short-chain fatty acid (postbiotic) production — the first fibre blend to do this, which is why it's patent-protected. We name every component fibre: FOS, inulin, resistant dextrin, resistant maltodextrin, partially hydrolysed guar gum (PHGG) and guar gum.
Clear free-from & certification status
Vegan (where applicable), gluten-free, non-GMO and preservative-free. Our Gut Health blend is Monash University Low FODMAP Certified™.
Tested and manufactured to high standards
Our blends are extensively tested through production, including gluten-free, contaminant and heavy-metal testing. We're committed to going further on public quality transparency — publishing batch-level certificates of analysis.
Our scientific team
Myota is founded by a team of scientists who have spent over 10 years conducting groundbreaking research into the gut microbiome.
Dr Thomas Gurry, PhD
- PhD in Computational and Systems Biology from MIT
- Postdoctoral researcher at the MIT Center for Microbiome Informatics and Therapeutics
- Active researcher on fibre fermentation by the gut microbiome
Selected publications
- Functional heterogeneity in the fermentation capabilities of the healthy human gut microbiota
- A library of human gut bacterial isolates paired with longitudinal multiomics data enables mechanistic microbiome research
- Predictability and persistence of prebiotic dietary supplementation in a healthy human cohort
Dr Caitlin Hall, APD, PhD
- PhD in gut microbiology and neurosciences, University of Queensland
- Accredited Practising Dietitian (BENS, MSc Dietetics)
- BDA Gastroenterology Specialist Group
Selected publications
- Effects of a diverse prebiotic fibre blend on inflammation, the gut microbiota and affective symptoms in metabolic syndrome: a pilot open-label randomised controlled trial
- Effects of a diverse prebiotic fibre supplement on HbA1c, insulin sensitivity and inflammatory biomarkers in pre-diabetes: a pilot placebo-controlled randomised clinical trial
Working in collaboration with
Our formulations and clinical trials are developed with leading microbiome and nutrition research groups.
Two blends. One decision.
One is certified low FODMAP for sensitive, unpredictable digestion. One is built for metabolic health. Both are the same science.
Explore our blends